Default Category
-
Lululemon: Stay Public or Go Private?
W. Glenn Rowe; Maria SemenovaCase IVEY-9B15M033-EStrategyAfter having virtually created the yoga-wear segment more than a decade earlier and having become a stock-market darling, Lululemon Athletica finds itself at a critical point in its development. After a series of missteps and a first-quarter profit drop of 60 per cent, the yoga-wear retailer’s founder, Chip Wilson, prepares to go into battle, meeting with banks and private equity firms to mount a buyout and take the company private. Similar to ot...Starting at €8.20
-
Cells For Life (B)
John G. Wilson; Robert Young; Georg Oppitz; Wayne Hoy; David BassinCase IVEY-9B09E011-ECorporate Governance, Service and Operations ManagementA biotech company receives umbilical cells for processing. A number of operational improvements are being considered in order to maintain the company's position and reputation in the market. Information on expected delivery dates is known. However, there is a great uncertainty around these dates. The company needs to take account of this variability when arranging for staffing.Starting at €5.74
-
Growth and Transition at Onex Corporation
W. Glenn Rowe; Rod E. White; Maria SemenovaCase IVEY-9B16M123-EStrategyOver its 30-year history, Onex Corporation, a Canadian investment firm, had derived much of its success from the private equity sector. It did so by acquiring attractive portfolio companies, adding value to them by improving their financial and operational performance, and then selling them several years later at an attractive return. However, given the market conditions in 2015, Onex Corporation faced difficulty in successfully acquiring target ...Starting at €8.20
-
Cells For Life (A)
John G. Wilson; Robert Young; Georg Oppitz; Wayne Hoy; David BassinCase IVEY-9B09E010-ECorporate Governance, Service and Operations ManagementA biotech company receives umbilical cells for processing. A number of operational improvements are being considered in order to maintain the company's position and reputation in the market. Information on expected delivery dates is known. However, there is a great uncertainty around these dates. The company needs to take account of this variability when arranging for staffing. A supporting data set is available, product 7B09E010 for the (A) case...Starting at €8.20